Searched for
ASTRAZENECA UK PROJECTS
Ahead of Market: 10 things that will decide stock market action on MondayIndian stock markets experienced sharp cuts on Thursday, with Nifty and Sensex declining due to rising oil prices and a falling rupee. Sell...- AstraZeneca plans to invest $405 million in Britain, PM Keir Starmer saysPrime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...
- AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 croreThe land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva...
- AstraZeneca India plans to sell North Bengaluru Unit for Rs 3,200 croreAstraZeneca Pharma India plans to sell its 64-acre Bengaluru facility as part of a strategic review by its parent company. The deal, estima...
- Stocks in news: IOL Chemicals, Alkyl Amines, Ola Electric, JSW Energy, Hero MotoCorpThe Indian arm of UK-headquartered pharmaceutical giant AstraZeneca has laid off more than 125 employees from its biopharmaceutical busines...
- How much protection does Covid booster dose provide against Omicron?The health experts reiterated that vaccines were still likely to offer good protection.
- IISc's 'warm' Covid vaccine effective against all major variants of concern: StudyAccording to S S Vasan, CSIRO's COVID-19 project leader and co-author of the study, the Mynvax-vaccinated mice sera show a strong response ...
- UK hits vaccine milestone, warns of 'deadly' misinformationThe Department of Health said that 75.2% of people 18 and over in the U.K. have received a shot, and 49.5% are fully vaccinated after two d...
- Covid vaccine: Why is AstraZeneca making so many unforced errors?The has been communication of scientific results. November data from trials in the U.K. and Brazil generated confusion over efficacy. This ...
- Six-week sprint got Indian-made AstraZeneca vaccine approved in CanadaLast week, when Health Canada approved AstraZeneca's COVID-19 vaccine, it also cleared a version of the shot made by the Serum Institute of...
- UK says vaccine manufacturing is 'lumpy' but still on course for targetsBritain has inoculated 3,857,266 people with a first dose and 449,736 with a second dose. On vaccines administered per 100 people, the Unit...
- How does AstraZeneca's vaccine compare with Pfizer-BioNTech?Britain on Wednesday became the first country to approve AstraZeneca and Oxford University's home-grown UK COVID-19 vaccine, adding an easy...
- Market movers: JMC Projects, Kalpataru Power get big orders; 120 stocks give buy signalThe Indian arm of British-Swedish pharma giant AstraZeneca Pharma gained 2.34 per cent to Rs 4,545.10 after the vaccine manufactured by the...
- Bulls maintain momentum for 6th day amid vaccine hopes; Nifty stops short of 14KAmong the bluechip names, UltraTech Cement was the top gainer, up 4.42 per cent. Its parent Grasim Industries, along with Shree Cement, Baj...
- Fortune or foresight? AstraZeneca and Oxford's stories clash on COVID-19 vaccineThe half-dose pattern was found to be 90% effective, versus the 62% success rate of the two-full-dose main study, based on interim data.
- AstraZeneca vaccine results a shot in the arm for IndiaThe AstraZeneca shot is one of India’s best hopes for an early vaccine. Unlike Pfizer and Moderna’s jab that have shown encouraging results...
- Covid-19 vaccine deliveries on ice as AstraZeneca awaits trial dataAstraZeneca said on Thursday it was holding back deliveries while it awaits the data from late-stage clinical trials in order to maximise t...
- Biopharma giant AstraZeneca begins coronavirus dual-use antibody drug trial in UKThe drug known as AZD7442 has the potential to be given as a preventative option for people exposed to the coronavirus, and to treat and pr...
- When it comes to a coronavirus vaccine, rich nations are first in lineAlthough international groups and a number of nations are promising to make vaccines affordable and accessible to all, doses will likely st...
- TCS, Infy need bigger deals to make gains in EuropeBigger contracts involve revenues from managed services and IT outsourcing, which are generally not subject to discretionary spend cuts. IT...
Load More
